Clinical efficacy of erlotinib, a salvage treatment for non-small cell lung cancer patients following gefitinib failure

BACKGROUND/AIMS: The purpose of this study was to identify predictive factors for erlotinib treatment in non-small cell lung cancer (NSCLC) patients following gefitinib failure. METHODS: Forty-five patients with NSCLC who were treated with erlotinib following gefitinib failure at Seoul National Univ...

Descripción completa

Detalles Bibliográficos
Autores principales: Cho, Kyoung Min, Keam, Bhumsuk, Kim, Tae Min, Lee, Se-Hoon, Kim, Dong-Wan, Heo, Dae Seog
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Association of Internal Medicine 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4642019/
https://www.ncbi.nlm.nih.gov/pubmed/26552465
http://dx.doi.org/10.3904/kjim.2015.30.6.891

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4642019/
https://www.ncbi.nlm.nih.gov/pubmed/26552465
http://dx.doi.org/10.3904/kjim.2015.30.6.891

Ejemplares similares